Similar articles

• Desensitization of prostaglandin-activated platelet adenylate cyclase.

  Cooper B, Schafer AI, Puchalsky D, Handin RI. Cooper B, et al. Prostaglandins. 1979 Apr;17(4):561-71. doi: 10.1016/0090-6980(79)90007-8. Prostaglandins. 1979. PMID: 461820
• Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis.

  Cooper B. Cooper B. Blood. 1979 Sep;54(3):684-93. Blood. 1979. PMID: 380688
• The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.

  Bonne C, Martin B, Watada M, Regnault F. Bonne C, et al. Thromb Res. 1981 Jan 1-15;21(1-2):13-22. doi: 10.1016/0049-3848(84)90028-8. Thromb Res. 1981. PMID: 6262942 No abstract available.
• Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.

  Whittle BJ, Hamid S, Lidbury P, Rosam AC. Whittle BJ, et al. Adv Exp Med Biol. 1985;192:109-25. doi: 10.1007/978-1-4615-9442-0_9. Adv Exp Med Biol. 1985. PMID: 2871707 Review. No abstract available.
• Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.

  MacIntyre DE, Bushfield M, MacMillan LJ, Moffat KJ, Murdoch FA, Thomson A, Rossi AG, McNicol A. MacIntyre DE, et al. Agents Actions Suppl. 1986;20:45-62. Agents Actions Suppl. 1986. PMID: 3028106 Review. No abstract available.